Japan
ADC Asia Congress 2027 is the region’s premier gathering dedicated to advancing Antibody-Drug Conjugates (ADCs), bringing together global innovators, biopharma leaders, researchers, manufacturers, investors, and solution providers from across the Asia-Pacific ecosystem. As ADCs continue to reshape the future of targeted cancer therapies, the congress serves as a strategic platform to explore the latest breakthroughs in discovery, conjugation technologies, payload development, manufacturing, clinical development, regulatory strategies, and commercialisation.
Designed to foster collaboration and accelerate innovation, the conference features high-level keynote presentations, technical case studies, panel discussions, and networking opportunities with leading pharmaceutical and biotechnology companies from across Asia and beyond. ADC Asia Congress 2027 offers attendees unparalleled access to industry insights, emerging trends, strategic partnerships, and business opportunities driving the next generation of precision medicine and oncology therapeutics.
Meet a highly concentrated audience of senior decision-makers, including VPs and Directors of ADC Early Development Bioconjugates/Bioconjugation, ADC Manufacturing & Process Development, Novel Modalities R&D, Heads of Toxicology and Pharmacokinetics, as well as Heads of Translational Medicine and Biology from leading biopharma hubs across the region.
A high-level gathering of leading ADC developers, bioconjugation specialists, CDMOs, global biopharma players, innovative biotech companies, and technology providers across Asia’s key biopharma hubs.
Hear from leading experts across Asia’s ADC landscape, including pioneers in ADC development, bioconjugation, manufacturing, process intensification, regulatory strategy, and next-generation therapeutic innovation. Gain insights from senior leaders driving advancement across the region’s top ADC companies and biopharma hubs.
Hear from past attendees and industry leaders
Japan
Singapore
Taiwan
Singapore
South Korea
China
Special thanks to our event partners, without whom we would not be able to provide this networking, learning, and collaborating platform.
CONFERENCE DAY 1 | 23rd March 2027 |
||||||
|
|
|
|
|
|
|
|
TRACK 1
|
TRACK 2
|
|||||
|
Leadership Panel Discussion
Building Asia's Global Leadership in Biologics, ADCs & Novel Modalities
|
Advancement in APAC
The Global Clinical Trials Hub
|
Resilient Supply Chains
Building Future-Ready Biopharma Supply Chains in Asia
|
Next-Generation Cell & Gene Therapies
CAR-T, Gene Editing & Emerging Modalities
|
Leadership Panel
RNA & Oligonucleotides Landscape in APAC
|
||
| Morning Tea Break | Exhibition Viewing & 1-1 Networking | ||||||
|
Upstream Processing
Robust Cell Lines & Optimized Expression Systems
|
Downstream Processing
Advancing Final Product Quality: Polishing, Viral Clearance & Formulation
|
Discovery
Innovative Pathways in ADC Discovery: Unlocking Next-Gen Targeting Strategies
|
Navigating the Future of Patient-Centric Trials
Patients Recruitment, Engagement, and Outreach
|
Next-Gen Cold Chain Logistics
Real-Time Visibility with Smart Devices
|
From Discovery to Clinical Translation
Accelerating CGT Development
|
Peptide Therapeutics 2.0
Beyond Metabolic Diseases
|
| Lunch Break | Exhibition Viewing & 1-1 Networking | ||||||
|
Upstream Processing
Process Intensification Strategies: Perfusion, Fed-Batch & High-Density Strategies
|
Analytics & Characterization
Next-Generation Methods for Product Quality & Process Excellence
|
Advancing Pre-Clinical Research
Bringing the Gap: From Pre-Clinical Insights to Clinical Success in ADC Development
|
Driving Sustainability in Cold and Ambient Chain Logistics
|
Gene & Cell Therapy Platforms
Vector Engineering, Delivery & Analytics
|
Delivery Technologies & Tissue Targeting
|
|
| Afternoon Tea Break | Exhibition Viewing & 1-1 Networking | ||||||
|
Downstream Processing
Refining Primary Recovery: Product Capture, Impurity Removal & Novel Methods
|
MSAT & Tech Transfer Excellence
Scale-Up, Validation & Lifecycle Management
|
Formulation & Stability
Ensuring ADC Stability & Optimized Formulation for Maximum Efficacy
|
Biomarker Driven Development
Linking Trials to Targeted Therapies
|
Smart Packaging & Traceability for Temperature-Sensitive Biologics
|
Smart Manufacturing & Process Development for CGTs
|
Oligonucleotide-Peptide Conjugates & Novel Modalities
|
| Asia Pacific Biopharma Excellence Awards 2027 | Gala Dinner | ||||||
CONFERENCE DAY 2 | 24th March 2027 |
||||||
|
|
|
|
|
|
|
|
CMC, Analytics & Quality
Achieving CMC Excellence, Integrated Analytics, Quality Control & Regulatory Readiness
|
Oncology Clinical Trials
New Modalities & Industry Innovation
|
Smart Supply Chain 4.0
Predictive Logistics, AI, Blockchain & Automation Use Cases
|
Advanced Cell Therapies
Beyond Traditional CAR-T
|
Clinical Development & Regulatory Excellence
|
||
| Morning Tea Break | Exhibition Viewing & 1-1 Networking | ||||||
|
Formulation, Development & Manufacturing
Stability, Drug Product Design & Commercialization
|
Smart, Agile and Digital Manufacturing
Flexible Facilities, Digital First Operations and Single Use System
|
Safety & Efficacy
Balancing Safety and Efficacy in ADCs: Overcoming Challenges for Effective Treatment
|
Transforming Clinical Trial Logistics in APAC
|
Manufacturing Excellence
Scale-Up, Tech Transfer & CMC Readiness
|
Manufacturing, CMC & Commercial Scale-Up
|
|
| Lunch Break | Exhibition Viewing & 1-1 Networking | ||||||
|
Process Analytics & Real-Time Manufacturing
PAT, Advanced Monitoring & Real-Time Release
|
Facility Engineering & Infrastructure Excellence
Designing, Operating & Future-Proofing Next-Generation Biomanufacturing Facilities
|
ADC Biopharma Showcase
Pioneering Innovation and Excellence in Antibody-Drug Conjugates
|
APAC CRO Showcase
From Early-Phase to Late-Stage: Showcasing End-to-End Clinical Research Capabilities
|
Meeting Regulatory Expectations & GxP Compliance in Asia
|
Supply Chain & Operational Excellence for CGTs
|
Quality, Analytics & Regulatory Innovation
|
| Afternoon Tea Break | Exhibition Viewing & 1-1 Networking | ||||||
|
Closing Roundtable Discussion
Bridging the Gaps: Practical Solutions for Manufacturing, Trials, Logistics & Drug Development in Asia
|
Regulatory Pathways, Market Access & Commercialization
|
Convergence of RNA, Peptides & Next-Generation Therapeutics
|
||||
| End of Conference | ||||||
Present Your Expertise to the Biopharma Industry's Key Stakeholders through a Variety of Available Speaking Packages.
Moderate a panel discussion including one representative from your company with 3 representatives from the end user side to share views on a current industry topic
Join in for dedicated CMO & CRO Showcases for German Market
Emphasize on your Message by Marketing and Promoting Alongside the Event
Gain Exclusive Access to Contacts of High Profile Attendees through Intimate Networking Opportunities
Tailored sponsorship opportunities designed to maximize your brand visibility and lead generation.
Don't miss out on unique networking, speaking and sponsorship opportunities.